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Prostate cancer is an increasing cause of malig-
nancy among men in Taiwan. According to the
2005 annual report from the Department of
Health in Taiwan, the incidence of prostate can-
cer rose from 1.45 per 100,000 persons in 1982
to 17.41 per 100,000 persons in 2002.1 In com-
parison with European countries and the United
States, the incidence of prostate cancer is far lower
in Taiwanese men.2,3 Pu proposed that the factors
that contribute to the increasing incidence of
prostate cancer in Taiwan are the introduction of
testing for prostate-specific antigen (PSA), popu-
lation aging and fat intake.4 Most clinical studies
of prostate cancer have been carried out on spec-
imens from radical prostatectomy, transrectal
biopsy or transurethral biopsy.5–9 From autopsy
and cystoprostatectomy studies, the incident pros-
tate cancer has been shown to be small-volume
(< 1 cm3) and low-grade (Gleason score < 6), and
it provides opportunities to investigate the evo-
lution of cancer.5–17 In autopsy studies, the prev-
alence of latent prostate cancer has been reported
to be 1.2–38.8% compared with 4.03–45% of
unsuspected prostate cancer in cystoprostatec-
tomy cases. However, a lack of autopsy materials
makes this type of study impractical in Taiwan.
Yang et al reported a rate of 32.7% for unsus-
pected prostate cancer in central Taiwan between
1992 and 1997.5 In their series, all of the unsus-
pected cases of prostate cancer were < 0.3 cm3, and
only 44% were > 0.1 cm3. We collected data from
cystoprostatectomies performed at our institute
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over the past 5 years, and compared them with
those from Yang et al’s study at the same insti-
tute, in order to investigate the change in unsus-
pected prostate cancer in central Taiwan.
Methods
Subjects
The study included 66 men who underwent cysto-
prostatectomy from January 2001 to December
2005. Among them, 64 had transitional cell car-
cinoma, one had squamous cell carcinoma, and
one had adenocarcinoma of the rectum with uri-
nary bladder invasion. One patient was excluded
because of a positive preoperative digital rectal
examination and pathologically proven prostate
cancer. The remaining 65 patients were assigned
to group 1. PSA level check-ups were not per-
formed routinely because of pyuria. All patients
in this group had normal digital rectal examina-
tions. Group 2 consisted of patients from a study
of unsuspected prostate cancer that was con-
ducted from 1992 to 1997 at the same institute.
Variables such as unsuspected prostate cancer
prevalence, percentage of high-grade prostatic 
intraepithelial neoplasia (HGPIN), tumor char-
acteristics, age distribution and tumor size were
compared between the two groups.
Histopathology
Each prostate specimen was fixed in 10% forma-
lin solution for 24–48 hours. Perpendicular sec-
tions were cut from the prostate apex to the base
at 4-mm intervals. Each slice was numbered con-
secutively, embedded in paraffin, and mounted
on glass slides. Hematoxylin and eosin staining
was performed and the slides were reviewed by
pathologists. The tumor volume was calculated
with a shrinkage factor of 1.5. HGPIN was diag-
nosed according to the method of Bostwick.18
Data analysis
Data analyzed included age, Gleason score of
prostate cancer, number of tumor foci, tumor vol-
ume, presence of HGPIN, and age-specific tumor
distribution. Between-group comparisons were
performed using Yates’ correction of contingency
or Fisher’s exact probability test when indicated.
Age-specific comparisons of tumor volume were
calculated using the Mann–Whitney U test.
Analyses were performed using SPSS version 10.1
(SPSS Inc., Chicago, IL, USA).
Results
Prevalence of prostate cancer was lower in group
1 than in group 2 (21.5% vs. 32.7%), although
this difference was not statistically significant. The
mean age in group 1 was 66.9 years (range, 35–87
years) and was no different from that in group 2
(mean, 68.5 years; range, 46–89 years). The preva-
lence of HGPIN decreased significantly in group
1 compared with group 2 (16.9% and 49%, re-
spectively, p = 0.0005), with a reduction of 65.5%.
The percentage of low-grade prostate cancer
(Gleason score 2–4) was significantly lower in
group 1 than in group 2 (50% vs. 87.5%; p=0.029).
There was no significant difference between the
two groups for moderate to high-grade cancer
(Gleason score 5–6 and 7–9) because of the small
number of cases. However, in group 1, the percent-
age of patients with a Gleason score of 5–6 was
nearly seven times higher than that in group 2.
There was also no statistically significant differ-
ence in tumor foci between the groups (Table 1).
Table 2 shows the age-specific comparison of 
unsuspected prostate cancer prevalence, significant
prostate cancer (tumor volume > 0.1 cm3) per-
centage and significant prostate cancer volume.
A significant increase in average cancer volume
was found in the 60–69 years age group.
Discussion
Our results suggest a decrease in the prevalence
of unsuspected prostate cancer in Taiwanese men
in central Taiwan when comparing cystoprostatec-
tomy specimens from the early days of PSA screen-
ing and the present. We found a histopathological
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progression in the period from 2001 to 2005, as
shown by an increase in the number of large-
volume tumors, advanced grade cancer, and multi-
focal cancer. Our results partially correspond to
those of Konety et al in their study of latent pros-
tate cancer rates after the advent of PSA screen-
ing, based on autopsy findings.16 In their series,
the rate of latent prostate cancer was 4.8% be-
tween 1955 and 1960, which decreased to 1.2%
between 1991 and 2001. Their results imply that
PSA screening may improve the rate of prostate
cancer detection and decrease the percentage of
patients with latent prostate cancer. They also
found a significant decrease in the proportion 
of moderate- to high-grade cancer, which was
different from our study. Konety et al examined
the prostate without whole-mount sections. 
According to the study of Breslow et al, a lack of
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Table 1. Comparison of prostate cancer differences in the two groups
Group 1 (2001–2005) Group 2 (1992–1997)
p
(n = 65) (n = 49)
Mean age (yr) 66.9 68.5
Unsuspected prostate cancer 0.263*
Positive 14 (21.5%) 16 (32.7%)
Negative 51 (78.5%) 33 (67.3%)
HGPIN 0.0005*†
Positive 11 (16.9%) 24 (49.0%)
Negative 54 (83.1%) 25 (51.0%)
Tumor foci 0.781*
Multiple 6 (42.9%) 5 (31.3%)
Solitary 8 (57.1%) 11 (68.8%)
Gleason score 0.029‡§
2–4 7 (50.0%) 14 (87.5%)
5–6 6 (42.9%) 1 (6.3%)
7–9 1 (7.1%) 1 (6.3%)
*Yates’ correction of contingency; †p < 0.01; ‡p < 0.05; §Fisher’s exact test.
Table 2. Age-specific comparison of two groups
Age (yr) Group 1 (2001–2005) Group 2 (1992–1997) p
Unsuspected prostate cancer percentage (percent/group case number)
30–59 12.5% (16) 25.0% (8) 0.578*
60–69 27.8% (18) 31.6% (19) 1.0†
70–89 22.6% (31) 36.4% (22) 0.431†
Significant prostate cancer (> 0.1 cm3) percentage (percent/group case number)
30–59 0.0 (2) 0.0 (2) —
60–69 80.0% (5) 33.3% (6) 0.242*
70–89 57.1% (7) 62.5% (8) 1.0*
Significant prostate cancer (> 0.1 cm3) volume (volume/group case number)
30–59 0.056 ± 0.044 (2) 0.039 ± 0.044 (2) 0.669‡
60–69 0.542 ± 0.291 (5) 0.070 ± 0.058 (6) 0.030§
70–89 0.191 ± 0.257 (7) 0.161 ± 0.133 (8) 0.694‡
*Fisher’s exact test; †Yates’ correction of contingency; ‡Mann–Whitney U test; §p < 0.05.
whole-mount section examination may lead to
an underestimation of cancer prevalence and in-
crease the study bias.19
Our results were at odds with those in the au-
topsy study by Yatani et al on latent prostate can-
cer rates in Japan.17 They found an increased
prevalence of latent prostate cancer in the periods
1965–1979 and 1982–1986 (22.5% vs. 34.6%).
They also observed a significant increase in the
proportion of moderate to poorly differentiated
tumors. In their study, the specimens were col-
lected from 10 different areas in Japan from
1965 to 1979 and from a single hospital from
1982 to 1986. This may have led to a selective
sampling bias. Their data were obtained in the
pre-PSA-screening era and there may have been
an underestimation of early prostate cancer.
HGPIN is considered to be a preclinical stage
of prostate cancer and may be regarded as im-
portant as unsuspected prostate cancer.14,18 We
found a significant decline in HGPIN in group 1
compared with group 2, and this corresponded
to a decrease in the percentage of patients with
unsuspected prostate cancer. Zigeuner et al used
specimens obtained from transurethral resection
of the prostate, and their results support our
findings.8 They reported that the incidence of
prostate cancer decreased by more than 50% in
the PSA screening era, with a concomitant de-
crease in HGPIN. They showed a decline in the
proportion of patients with unsuspected prostate
cancer and HGPIN, and an increase in tumor
volume and grading.
Considering the increased PSA detection in
early prostate cancer, the decline in unsuspected
prostate cancer may have been expected. Why did
the tumor volume and grade progress? Two fac-
tors may have influenced these results. Taiwan
has been a rapidly developing country during the
past few decades of economic boom. The west-
ernization of society is different from the United
States and may have been associated with the 
increase of prostate cancer incidence during this
period. It is also interesting that the rate of large-
volume cancer increases in the 60–69 years age
group. Taiwanese at this age may experience larger
social and lifestyle change during their lives than
the other two decades of people and this could
possibly be the cause of the result. In the other two
age groups, young people are seldom found with
prostate cancer due to potentially low incidence
in the whole population; the older people were
willing to maintain their previous lives and were
found to have no change in the observation.
There were four limitations to this study. First,
the number of cases was small, so the differences
between the two groups were not readily appar-
ent. Second, the tumor volume of most unsus-
pected prostate cancer cases was small. Although
whole-mount sections were used in both study
groups, pathological errors may still have been
present. Third, the period gap between these two
groups was short and the influence of environ-
mental factors and any background effects may
not have been significant. Fourth, our study was
performed from a single institute in central Taiwan.
The results may have been regional. Lee et al re-
ported only 4.03% of unsuspected prostate can-
cer in northern Taiwan.20 Although there were
differences in the patient selection and histo-
pathological management, a regional discrepancy
may have existed.
Our study does provide epidemiological re-
sults from a developing country. It is helpful in
the study of public health and the evolution of
prostate cancer. Further studies in this field may
help in differentiating the predisposing factors of
prostate cancer in Taiwan.
Acknowledgments
We would like to thank the Biostatistics Task
Force, Taichung Veterans General Hospital for
their help with the statistical analysis.
References
1. Department of Health, Executive Yuan, Taiwan, R.O.C.
Cancer Registry Annual Report, 2002. Taipei: Department
of Health, Executive Yuan, Taiwan, R.O.C.
J.R. Li, et al
412 J Formos Med Assoc | 2009 • Vol 108 • No 5
2. Hudson T, Denis LJ. Europa Uomo: the European Prostate
Cancer Coalition. Recent Results Cancer Res 2007;175:
267–71.
3. U.S. Cancer Statistics Working Group. United States
Cancer Statistics: 2002 Incidence and Mortality. Atlanta:
U.S. Department of Health and Human Services, Centers
for Disease Control and Prevention and National Cancer
Institute, 2005.
4. Pu YS. Prostate cancer in Taiwan: epidemiology and risk
factors. Int J Andro 2000;23:34–6.
5. Yang CR, Ou YC, Ho HC, et al. Unsuspected prostate car-
cinoma and prostatic intraepithelial neoplasm in Taiwan-
ese patients undergoing cystoprostatectomy. Mole Urol
1999;3:33–9.
6. Stamey TA, Freiha FS, McNeal JE, et al. Localized prostate
cancer: relationships of tumor volume to clinical significance
for treatment of prostate cancer. Cancer 1993:71(Suppl):
933–8.
7. McNeal JE, Bostwick DG, Kindrachuk RA, et al. Patterns
of progression in prostate cancer. Lancet 1986;1:60–3.
8. Zigeuner RE, Lipsky K, Riedler I, et al. Did the rate of inci-
dental prostate cancer change in the era of PSA testing? 
A retrospective study of 1127 patients. Urology 2003;62:
451–5.
9. Prange W, Erbersdobler A, Hammerer P, et al. Signifi-
cance of high-grade prostatic intraepithelial neoplasia in
needle biopsy specimens. Urology 2001;57:486–90.
10. Billis A. Latent carcinoma and atypical lesions of prostate:
an autopsy study. Urology 1986;28:324–9.
11. Pritchett TR, Moreno J, Warner NE, et al. Unsuspected
prostatic adenocarcinoma in patients who have undergone
radical cystoprostatectomy for transitional cell carcinoma
of the bladder. J Urol 1988;139:1214–6.
12. Kabalin JN, McNeal JE, Price HM, et al. Unsuspected ade-
nocarcinoma of the prostate in patients undergoing cysto-
prostatectomy for other causes: incidence, histology and
morphometric observations. J Urol 1989;141:1091–4.
13. Abbas F, Hochberg D, Civantos F, et al. Incidental pros-
tatic adenocarcinoma in patients undergoing radical cys-
toprostatectomy for bladder cancer. Eur Urol 1996;30:
322–6.
14. Wiley EL, Davidson P, McIntire DD, et al. Risk of concur-
rent prostate cancer in cystoprostatectomy specimens is
related to volume of high-grade prostatic intraepithelial
neoplasia. Urology 1997;49:692–6.
15. Soos G, Tsakiris I, Szanto J, et al. The prevalence of pros-
tate carcinoma and its precursor in Hungary: an autopsy
study. Eur Urol 2005;48:739–44.
16. Konety BR, Bird VY, Deorah S, et al. Comparison of the 
incidence of latent prostate cancer detected at autopsy
before and after the prostate specific antigen era. J Urol
2005;174:1785–8.
17. Yatani R, Shiraishi T, Nakakuki K, et al. Trends in fre-
quency of latent prostate carcinoma in Japan from
1965–1979 to 1982–1986. J Natl Cancer Inst 1988;80:
683–7.
18. Bostwick DG. High grade prostatic intra-epithelial neopla-
sia: the most likely precursor of prostate cancer. Cancer
1995;75(Suppl):1823–36.
19. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of
prostate at autopsy in seven areas. Collaborative study 
organized by the International Agency for Research on
Cancer, Lyons, France. Int J Cancer 1977;20:680–8. 
20. Lee SH, Chang PL, Chen SM, et al. Synchronous primary
carcinomas of the bladder and prostate. Asian J Androl
2006;8:357–9.
Unsuspected prostate cancer in Taiwan 
J Formos Med Assoc | 2009 • Vol 108 • No 5 413
